Salmeterol 50mcg + Fluticasone Propionate 500mcg dry powder capsule is a high-potency combination inhalation therapy used for the management of moderate to severe asthma and COPD, helping improve lung function and reduce respiratory symptoms.
Salmeterol provides long-acting beta-2 adrenergic bronchodilation, relaxing bronchial smooth muscles, while Fluticasone Propionate delivers powerful anti-inflammatory corticosteroid action, reducing airway inflammation and hyperresponsiveness.
This capsule is commonly prescribed for maintenance therapy in patients with persistent asthma, chronic bronchitis, and severe COPD, aiding in symptom control, prevention of exacerbations, and improvement of overall pulmonary health.
With clinically proven dual-action efficacy, patient-friendly dry powder inhalation delivery, and reliable symptom management, this formulation strengthens a respiratory therapy portfolio and ensures consistent demand for chronic respiratory care.